These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 33151933)
1. Mathematical modeling of hepatitis C RNA replication, exosome secretion and virus release. Zitzmann C; Kaderali L; Perelson AS PLoS Comput Biol; 2020 Nov; 16(11):e1008421. PubMed ID: 33151933 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Is Released via a Noncanonical Secretory Route. Bayer K; Banning C; Bruss V; Wiltzer-Bach L; Schindler M J Virol; 2016 Dec; 90(23):10558-10573. PubMed ID: 27630244 [TBL] [Abstract][Full Text] [Related]
3. Identification of HNRNPK as regulator of hepatitis C virus particle production. Poenisch M; Metz P; Blankenburg H; Ruggieri A; Lee JY; Rupp D; Rebhan I; Diederich K; Kaderali L; Domingues FS; Albrecht M; Lohmann V; Erfle H; Bartenschlager R PLoS Pathog; 2015 Jan; 11(1):e1004573. PubMed ID: 25569684 [TBL] [Abstract][Full Text] [Related]
4. The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C Virus. Elgner F; Ren H; Medvedev R; Ploen D; Himmelsbach K; Boller K; Hildt E J Virol; 2016 Dec; 90(24):11181-11196. PubMed ID: 27707921 [TBL] [Abstract][Full Text] [Related]
5. Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro. Castet V; Fournier C; Soulier A; Brillet R; Coste J; Larrey D; Dhumeaux D; Maurel P; Pawlotsky JM J Virol; 2002 Aug; 76(16):8189-99. PubMed ID: 12134024 [TBL] [Abstract][Full Text] [Related]
6. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release. Wang Q; Li Y; Liu SA; Xie W; Cheng J World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605 [TBL] [Abstract][Full Text] [Related]
7. In vitro replication models for the hepatitis C virus. Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638 [TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells. Dahari H; Ribeiro RM; Rice CM; Perelson AS J Virol; 2007 Jan; 81(2):750-60. PubMed ID: 17035310 [TBL] [Abstract][Full Text] [Related]
9. A compartmentalization model of hepatitis C virus replication: an appropriate distribution of HCV RNA for the effective replication. Nakabayashi J J Theor Biol; 2012 May; 300():110-7. PubMed ID: 22286015 [TBL] [Abstract][Full Text] [Related]
10. A Cell Culture Model for Persistent HCV Infection. Castro V; Ávila-Pérez G; Mingorance L; Gastaminza P Methods Mol Biol; 2019; 1911():157-168. PubMed ID: 30593624 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus (HCV) induces formation of stress granules whose proteins regulate HCV RNA replication and virus assembly and egress. Garaigorta U; Heim MH; Boyd B; Wieland S; Chisari FV J Virol; 2012 Oct; 86(20):11043-56. PubMed ID: 22855484 [TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents. Shahidi M; Tay ESE; Read SA; Ramezani-Moghadam M; Chayama K; George J; Douglas MW J Gen Virol; 2014 Nov; 95(Pt 11):2468-2479. PubMed ID: 25053565 [TBL] [Abstract][Full Text] [Related]
14. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. Guedj J; Neumann AU J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874 [TBL] [Abstract][Full Text] [Related]
16. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System. Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847 [TBL] [Abstract][Full Text] [Related]
17. The science of direct-acting antiviral and host-targeted agent therapy. Pawlotsky JM Antivir Ther; 2012; 17(6 Pt B):1109-17. PubMed ID: 23188746 [TBL] [Abstract][Full Text] [Related]
18. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Ramakrishnaiah V; Thumann C; Fofana I; Habersetzer F; Pan Q; de Ruiter PE; Willemsen R; Demmers JA; Stalin Raj V; Jenster G; Kwekkeboom J; Tilanus HW; Haagmans BL; Baumert TF; van der Laan LJ Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13109-13. PubMed ID: 23878230 [TBL] [Abstract][Full Text] [Related]
19. The hepatitis C virus life cycle as a target for new antiviral therapies. Pawlotsky JM; Chevaliez S; McHutchison JG Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890 [TBL] [Abstract][Full Text] [Related]
20. Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]